Načítá se...
Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
Renewing interest in immune aspects of schizophrenia and new findings about the brain-fat axis encourage us to discuss the possible role of interleukin-6 (IL-6) in schizophrenia. Previously, it was suggested that a primary alteration of the innate immune system may be relevant in schizophrenia. Func...
Uloženo v:
| Vydáno v: | Front Psychiatry |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5681495/ https://ncbi.nlm.nih.gov/pubmed/29163240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2017.00221 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|